The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeneca Growth Regulatory News (HYG)

Share Price Information for Seneca Growth (HYG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.50
Bid: 10.00
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 7.00 (70.00%)
Open: 13.50
High: 13.50
Low: 13.50
Prev. Close: 13.50
HYG Live PriceLast checked at -
Seneca Growth Capital VCT is an Investment Trust

To provide shareholders with an attractive income and capital return by investing its funds in a portfolio of both unquoted and quoted UK MedTech companies which meet the relevant criteria under the VCT Rules.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

24 Oct 2013 15:53

RNS Number : 3543R
Hygea VCT plc
24 October 2013
 



24 October 2013

 

 

HYGEA VCT PLC

 

INTERIM MANAGEMENT STATEMENT

 

 

Hygea vct plc ('the Company') presents its interim management statement for the period from 1 July 2013 to 24 October 2013. This constitutes the Company's second interim management statement for the financial year ending 31 December 2013, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3. This statement has been prepared solely to provide additional information in order to meet the requirements of the Disclosure and Transparency Rules and should not be relied on by shareholders, or any other party, for any other purpose.

 

The unaudited net asset value per ordinary share and the number of shares in issue at 30 September 2013 were 102.0p and 8,115,376 respectively (30 June 2013: 112.8p and 8,115,376 respectively). The net asset value at 30 September 2013 is stated after accruing for the interim dividend of 3p per share payable on 25 October 2013. There were no shares held in Treasury at either date.

 

No shares have been issued or repurchased during the period.

 

At 30 September 2013, the Company's assets included its portfolio of unlisted assets along with £382,785 in cash and £6,179,935 in AIM traded shares valued at bid price. The Scancell plc ('Scancell') share price declined from 44.1p at 30 June 2013 to 39.0p at 30 September 2013. This has further fallen to 31.25p at 23 October 2013. As previously reported, 500,000 Scancell shares have been sold during the period realising net proceeds of £246,300 leaving the Company owning 13,349,730 shares. In view of the significance of the Scancell holding within the portfolio, readers' attention is drawn to the recording dated 4 October 2013 of Scancell's investor day accessible on www.scancell.co.uk.

 

During the three months ended 30 September 2013, the Company made a further investment of £100,008 into Eykona Technologies Limited and £200,000 into OR Productivity Limited.

 

The Directors are not aware of any other events which have taken place between 30 September 2013 and the date of publication of this statement, which have had a material effect on the financial position of the Company.

 

 

Enquiries:

James Otter, Hygea vct plc on 01730 829877 or james.otter@ellipson.co.uk 

Charles Breese, Hygea vct plc on 01280 703482 or larpentnewton@btinternet.com

Roland Cornish, Beaumont Cornish Limited on 020 7628 3396

 

website: www.hygeavct.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUSVSROUARUAA
Date   Source Headline
22nd Apr 202410:46 amGNWShare Buy-back and Total Voting Rights
5th Apr 202412:44 pmGNWIssue of Equity and Total Voting Rights
4th Apr 20247:00 amGNWNet Asset Value(s)
28th Mar 202412:11 pmGNWIssue of Supplementary Prospectus
22nd Mar 20247:00 amGNWFinal Results, Notice of AGM, Updated NAV
7th Mar 20247:00 amGNWInterim Dividend on B Shares
19th Feb 20244:36 pmGNWDirector Declaration
21st Dec 202312:03 pmGNWIssue of Equity and Total Voting Rights
6th Dec 20233:24 pmGNWDirector/PDMR Dealing
6th Dec 20233:14 pmGNWIssue of Equity and Total Voting Rights
29th Nov 202312:36 pmGNWChange of the Company’s Auditor
20th Nov 20233:20 pmGNWB Share Buy-back and Total Voting Rights
3rd Nov 20237:00 amGNWDividend Declaration
12th Oct 20237:00 amGNWNet Asset Value(s)
11th Oct 20233:39 pmGNWDirectorate Change
24th Aug 20234:18 pmGNWOffer for Subscription and Publication of Prospectus
18th Aug 20235:08 pmGNWIssue of Equity and Total Voting Rights and Capital Reorganisation
2nd Aug 202311:40 amGNWHalf-year Report
30th Jun 20231:58 pmGNWIssue of Equity and Total Voting Rights
20th Jun 20238:50 amGNWShare Buy-back and Total Voting Rights
18th May 20231:38 pmGNWDirectorate Changes
18th May 20231:32 pmGNWResults of Annual General Meeting Voting
3rd May 20234:01 pmGNWIssue of Equity and Total Voting Rights
27th Apr 202311:25 amGNWPublication of a Supplementary Prospectus
21st Apr 20237:00 amGNWFinal Results for the Year Ended 31 December 2022
5th Apr 20233:05 pmGNWIssue of Equity and Total Voting Rights
4th Apr 20237:00 amGNWNet Asset Value(s)
7th Mar 20231:30 pmGNWInterim Dividend Declarations
21st Dec 20227:00 amGNWB Share Portfolio Update
7th Dec 20227:00 amGNWOrdinary Share NAV Update and Dividend Declaration
30th Nov 202212:33 pmGNWDirector/PDMR Shareholding
30th Nov 202212:29 pmGNWIssue of Equity and Total Voting Rights
19th Oct 20227:00 amGNWSecond Interim Dividend on B Shares
13th Oct 20227:00 amGNWNAV Update
26th Aug 202211:56 amGNWOffer for Subscription and Publication of Prospectus
22nd Aug 20222:53 pmGNWPDMR Shareholding
22nd Aug 20222:46 pmGNWIssue of Equity and Total Voting Rights
16th Aug 20227:00 amGNWB Share Closure of Offer for Subscription
15th Jul 20227:00 amGNWHalf-year report
30th Jun 202210:17 amGNWIssue of Supplementary Prospectus
23rd May 20227:00 amGNWAppointment of Auditor
23rd May 20227:00 amGNWShare Buy-back and TVR
4th May 202211:25 amGNWIssue of Equity and Total Voting Rights
27th Apr 20223:42 pmGNWResult of AGM
5th Apr 20221:56 pmGNWIssue of Equity and Total Voting Rights
1st Apr 20221:43 pmGNWIssue of Equity and Total Voting Rights
1st Apr 202211:05 amGNWNAV Update
25th Mar 202210:00 amGNWIssue of Supplementary Prospectus
25th Mar 20227:01 amGNWNAV Update
25th Mar 20227:00 amGNWFinal Results for the Year Ended 31 December 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.